Skip to content

Efficacy of Automated Bolus Calculation in Type 2 Diabetes

Efficacy of Advanced Carbohydrate Counting and Automated Bolus Calculation in Insulin-treated Type 2 Diabetes Patients: The BolusCal2 Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02887898
Acronym
BolusCal2
Enrollment
80
Registered
2016-09-02
Start date
2016-09-30
Completion date
2018-11-30
Last updated
2020-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

The investigators hypothesize that non-optimal basal-bolus insulin treated patients with type 2 diabetes can achieve better metabolic control by counting carbohydrates with concurrent use of an automated bolus calculator. Additionally, the investigators propose that this intervention will lead to improvement in patient related outcomes.

Interventions

OTHEREducation

Sponsors

Hvidovre University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetes \> 1 year * Age 18 years or older * HbA1C \> 64 mmol/mol (8.0 %) * Treatment with multiple daily insulin injections (basal and prandial insulin) ≥ 6 months * GAD-antibody negative * Naïve to bolus calculators

Exclusion criteria

* Pregnancy or breast feeding * Gastroparesis * Severe nephropathy (eGFR\<30 mL/min/1,73 m2) * Use of sulfonylurea

Design outcomes

Primary

MeasureTime frame
Change in HbA1c6 months

Secondary

MeasureTime frameDescription
Time spent below, in or above the glucose target 4-10 mmol/l measured by continuous glucose monitoring (CGM)6 months
Frequency of blood glucose measurements assessed by meter download before randomization and at each visit6 months
Change in diet habits/diet composition6 monthsAssessed by electronic diet recordings
Change in treatment satisfaction6 monthsUsing questionnaire
Frequency of hypoglycemia (below 2.8 mmol/L or unconsciousness/ need of medical assistance)6 months

Other

MeasureTime frameDescription
Adherences to bolus calculator use6 monthsUsing questionnaire

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026